RO 31-8220 and RO 31-7549 show improved selectivity for protein kinase C over staurosporine in macrophages

Add time:08/25/2019    Source:sciencedirect.com

SummaryTwo new potent protein kinase C inhibitors, RO 31-8220 and RO 31-7549, and staurosporine were found to inhibit dose-dependently the phorbol ester-induced formation of prostaglandin E2and superoxide in cultured liver macrophages. Prostaglandin E2formation from exogenously added arachidonate was not affected by these compounds. The zymosan-induced formation of inositol phosphates was decreased by simultaneous addition of phorbol ester and was enhanced by prior desensitization of protein kinase C indicating that protein kinase C negatively modulates phospholipase C activation in these cells. While staurosporine suppressed almost totally the zymosan-induced formation of inositol phosphates, RO 31-8220 and RO 31-7549 inhibited the protein kinase C-mediated effect on inositol phosphate formation, only. Phagocytosis of zymosan was not affected by RO 31-8220 and RO 31-7549 but was decreased by staurosporine. These results demonstrate that two new potent protein kinase C inhibitors, RO 31-8220 and RO 31-7549, are more selective in their actions as staurosporine and are useful tools to determine an involvement of protein kinase C in cellular systems.

We also recommend Trading Suppliers and Manufacturers of RO-31-8220 (cas 138489-18-6). Pls Click Website Link as below: cas 138489-18-6 suppliers

Prev:Ro 31-8220
Next:Dissociation of tyrosine phosphorylation and activation of phosphoinositide phospholipase C induced by the protein kinase C inhibitor RO-31-8220 (cas 138489-18-6) in Swiss 3T3 cells treated with platelet-derived growth factor)